STRC Gene Deafness Autosomal Recessive Type 16 Genetic Test
Cost: AED 4400.0
Test Components: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Ear Nose Throat Disorders
Doctor: ENT Doctor
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER7
Test Details
Deafness, autosomal recessive type 16 (DFNB16) is a genetic disorder that is characterized by hearing loss that is present from birth. It is caused by mutations in the STRC gene.
NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of various genetic mutations, including those associated with DFNB16.
The STRC gene is responsible for providing instructions for the production of a protein called stereocilin. This protein is important for the proper functioning of hair cells in the inner ear, which are essential for hearing. Mutations in the STRC gene can lead to a reduction or loss of stereocilin production, resulting in hearing loss.
NGS genetic testing for DFNB16 involves sequencing the STRC gene to identify any mutations or variations that may be present. This information can help in diagnosing the condition and determining the inheritance pattern within families. It can also assist in providing appropriate genetic counseling and management options for affected individuals and their families.
It is important to note that genetic testing for DFNB16 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results accurately and provide appropriate guidance and support.
| Test Name | STRC Gene Deafness autosomal recessive type 16 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER7 |
| Test Details |
Deafness, autosomal recessive type 16 (DFNB16) is a genetic disorder that is characterized by hearing loss that is present from birth. It is caused by mutations in the STRC gene. NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of various genetic mutations, including those associated with DFNB16. The STRC gene is responsible for providing instructions for the production of a protein called stereocilin. This protein is important for the proper functioning of hair cells in the inner ear, which are essential for hearing. Mutations in the STRC gene can lead to a reduction or loss of stereocilin production, resulting in hearing loss. NGS genetic testing for DFNB16 involves sequencing the STRC gene to identify any mutations or variations that may be present. This information can help in diagnosing the condition and determining the inheritance pattern within families. It can also assist in providing appropriate genetic counseling and management options for affected individuals and their families. It is important to note that genetic testing for DFNB16 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results accurately and provide appropriate guidance and support. |
